CONAVI MEDICAL CORP (CNVI.CA) Stock Income Statement
TSX-V:CNVI - CA2059531020 - Common Stock
0.45 CAD
-0.02 (-4.26%)
| TTM (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.69M | 24.20M | 0.00 | 27.58M | 20.00M | |||
| Operating Expenses | 16.59M | 11.92M | 61.45M | 70.11M | 15.80M | |||
| Research and Development | 8.47M | 440.60K | 45.30M | 52.09M | 7.94M | |||
| Selling, General, and Administrative Expenses | 7.48M | 11.22M | 14.97M | 17.05M | 7.63M | |||
| Operating Income | -9.36M | 12.28M | -61.45M | -42.53M | 4.20M | |||
| Interest Income/Expense | -11.35M | 635.50K | 6.16M | 21.38M | -29.04M | |||
| Other Income/Expense | N/A | 144.10K | 0.00 | 830.40K | -1.82M | |||
| Non Recurring Items | -4.86M | -3.81M | -3.18M | 0.00 | 2.47M | |||
| Income Before Taxes | -14.19M | 9.58M | -58.47M | -20.32M | -24.18M | |||
| Income Tax | N/A | 32.90K | -76.90K | 76.90K | N/A | |||
| Net Income | -14.19M | 9.54M | -58.39M | -20.39M | -24.18M | |||
| EBITDA | N/A | 12.54M | -60.27M | -41.57M | 4.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.13 | 0.08 | -0.52 | -0.19 | -0.36 | |||
| Statistics | ||||||||
| Profit Margin | -163.28% | 39.43% | N/A | -73.95% | -120.90% | |||
| Operating Profit Margin | -107.69% | 50.75% | N/A | -154.22% | 21.00% | |||
All data in CAD